Stay updated on Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of a clinical study involving the combination of Azacitidine and Ruxolitinib for the treatment of higher-risk MDS/MPN.
    Difference
    0.3%
    Check dated 2024-06-06T14:26:53.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value for the 'Last Update Posted' field has changed from 6 to 7. This indicates that the study record for the clinical trial involving Azacitidine combined with Ruxolitinib in the treatment of higher-risk MDS/MPN has been updated recently.
    Difference
    0.3%
    Check dated 2024-05-22T21:22:58.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:47:02.000Z thumbnail image

Stay in the know with updates to Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.